肝细胞癌与非肝细胞癌:肝脏影像报告和数据系统v2018的准确性与可靠性
该回顾性研究纳入两家肝移植中心10年经病理证实的原发肝脏恶性肿瘤,共105例肝细胞癌和73例非肝细胞癌,由两名盲法阅片者独立评估并赋予LI-RADS诊断分类。LI-RADS鉴别肝细胞癌与非肝细胞癌的特异度高(阅片者1为89%,阅片者2为90%),最终分类及多数征象的阅片者间信度为中等至较高。v2018诊断算法修订导致极少数病灶重新分类(阅片者1为5例(2.8%),阅片者2为3例(1.7%))。
要点
- LI-RADS鉴别肝细胞癌与非肝细胞癌原发肝脏恶性肿瘤的特异度高(阅片者1为89%,阅片者2为90%)。
- 最终LI-RADS分类及多数征象的阅片者间信度为中等至较高。
- v2018诊断算法修订仅使极少数病灶重新分类(阅片者1为5例(2.8%),阅片者2为3例(1.7%))。
核心结论
- LI-RADS诊断分类及征象的阅片者间信度为中等至较高,鉴别肝细胞癌与非肝细胞癌原发肝脏恶性肿瘤的特异度高;v2018诊断算法修订导致极少数病灶重新分类。
研究设计与样本
- 回顾性研究,合并两家大型肝移植中心10年经病理证实的原发肝脏恶性肿瘤,最终队列包括105例肝细胞癌和73例非肝细胞癌原发肝脏恶性肿瘤;两名盲法阅片者独立评估每个病灶并赋予LI-RADS诊断分类,同时对所有相关影像征象评分;由研究协调员评估基于阅片者所提供征象及新v2018标准的分类变化。
诊断标准与关键数值
- LI-RADS鉴别肝细胞癌与非肝细胞癌的特异度:阅片者1为89%,阅片者2为90%;最终LI-RADS分类及多数征象的阅片者间信度为中等至较高。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The Liver Imaging Reporting and Data System (LI-RADS) was created to standardize the diagnostic criteria for hepatocellular carcinoma (HCC) and has undergone multiple revisions including a recent update in 2018 (v2018). The primary aim of this study was to determine the diagnostic performance and interrater reliability (IRR) of LI-RADS v2018 for distinguishing HCC from non-HCC primary hepatic malignancy in patients 'at-risk' for HCC. A secondary aim was to assess the impact of changes introduced in the v2018 diagnostic algorithm.
METHODS: This retrospective study combined a 10-year experience of pathologically proven primary liver malignancies from two large liver transplant centers. Two blinded readers independently evaluated each lesion and assigned a LI-RADS diagnostic category, additionally scoring all relevant imaging features. Changes in category based on the reader-provided features and the new v2018 criteria were assessed by a study coordinator.
RESULTS: The final study cohort comprised 105 HCCs and 73 non-HCC primarily liver malignancies. LI-RADS had a high specificity for distinguishing HCC from non-HCC (89% and 90% for reader 1 and reader 2, respectively), and IRR was moderate to substantial for final LI-RADS category and most features. Revision of the LI-RADS v2018 diagnostic algorithm resulted in very few changes [5 (2.8%) and 3 (1.7%) for reader 1 and reader 2, respectively] in overall lesion classification.
CONCLUSION: LI-RADS diagnostic categories and features had moderate to substantial IRR and high specificity for distinguishing HCC from non-HCC primary liver malignancy. Revision of LI-RADS v2018 diagnostic algorithm resulted in reclassification of very few lesions.
引用
- Ludwig DR, Fraum TJ, Cannella R, et al. Hepatocellular carcinoma (HCC) versus non-HCC: accuracy and reliability of Liver Imaging Reporting and Data System v2018. Abdom Radiol (NY). 2019. PMID: 30798397. doi:10.1007/s00261-019-01948-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。